Thursday, May 30, 2013

خطوات الفحص الذاتي للكشف المبكر عن سرطان الثدي


كيف تقومين بعمل الفحص الذاتي؟
Photo Credit: Wikipedia
يبلغ ما يتم اكتشافه من سرطان الذي عن طريق النساء أنفسهن باستخدام الفحص الذاتي نصف ما يكتشفه الأطباء بالفحص الطبي.
كلما صغر حجم الورم كلما أمكن علاجه بسهولة والسيطرة عليه.
يجب أن تتعلم المرأة طريقة الفحص الذاتي وتقوم بالمواظبة عليه من سن البلوغ حتى سن الشيخوخة.
يمكن القيام بالفحص الذاتي من اليوم السادس وحتى اليوم العاشر من بداية الدورة الشهرية.
في حالة انقطاع الطمث (على سبيل المثال بعد انقطاع الطمث بعد ازالة الرحم) يتم القيام بالفحص الذاتي في يوم ثابت شهرياً.
يجب أيضاً على النساء الحوامل أو من خضعن لعمليات زراعة الثدي القيام بالفحص الذاتي بصورة شهرية.
يجب على النساء المرضعات القيام بالفحص الذاتي بعد تفريغ الحليب.
الخطوات الأربعة للقيام بالفحص الذاتي الشهري
قبل البدء بالاختبار قومي باختيار حركة واحدة لاستخدامها في كل مرة تقومين فيها بإجراء الفحص وهذا يجعل من السهل بالنسبة لك اكتشاف أي تغيرات في الثدي.
1.    الحركة الدائرية
2.    الحركة صعوداً ونزولاً
3.    الحركة الضاغطة

الخطوة الأولى : الاستلقاء
قومي بوضع وسادة تحت كتفك الأيمن.
ضعي يدك اليمنى خلف رأسك.
استخدمى الأطراف الداخلية للأصابع الثلاثة الوسطى ليدك اليسرى ابحثي عن أي تغييرات في الثدي وتحت الترقوة ومنطقة الإبط (مثل وجود تورم أو كتلة صلبة أو سماكة في الجلد.)
كرري نفس الخطوات مع الثدي الأيسر.
الخطوة الثانية : الوقوف أمام المرآة بشكل مستقيم
ضعي يدك اليمنى خلف رأسك.
استخدام الأصابع الثلاثة الوسطى ليدك اليسرى بينما تفحصين الثدي الأيمن.
قومي بفحص جميع مناطق الثدي وعظمة الترقوة مثلما فعلت عند الاستلقاء.
كرري نفس الخطوات مع الثدي الأيسر باستخدام يدك اليمنى.
الخطوة الثالثة : الوقوف أمام المرآة بشكل مستقيم
ضعي ذراعيك فوق رأسك.
قومي بفحص الثدي للتأكد من ما اذا كان هناك أي تغيير في الشكل والحجم واللون.
الخطوة الرابعة : الوقوف أمام المرآة بشكل مستقيم
اضغطي بذراعيك على الوركين وقومي بالانحناء إلى الأمام.
قومي بفحص الثدي للتأكد من ما اذا كان هناك بروز أو نتوء أو افراز أو طفح على الحلمة أو أي من المظاهر الشكلية الغير طبيعية.
ما الذي تبحثين عنه عند القيام بالفحص الذاتي؟
1.    وجود نتوء أو كتلة صلبة أو سماكة في الجلد.
2.    وجود تورم أو ارتفاع في الحرارة أو احمرار أو سواد.
3.    وجود تغيير في حجم أو شكل الحلمة أو الثدي.
4.    وجود تجعد أو تنقير في الجلد.
5.    وجود حكة أو التهاب أو طفح جلدي أو قشور على الحلمة.
6.    ضمور في الحلمة أو أجزاء أخرى من الثدي.
7.    إفرازات من الحلمة (خاصة لو دموية) والتي قد تكون بدأت بصورة فجائية.
8.    ألم مستمر في بقعة معينة.
9.    شعور بألم في الثدي غير الذي يرتبط بالدورة الشهرية.


Women Deliver » Updates » Girls’ & Women’s Health and Rights in Focus at Women Deliver 2013 in Kuala Lumpur

For more information, please contact:
Janna Oberdorf, Women Deliver
joberdorf@womendeliver.org
+60 (0)11-23 326 420
Jessica Freifeld, Global Health Strategies
jfreifeld@globahealthstrategies.com
+60 (0)11 23 326 315
Malaysian Prime Minister Honourable Dato' Sri Mohd Najib bin Tun Abdul Razak and other global luminaries
open largest conference on girls and women of the decade
World Bank and Guttmacher Institute release new data on the value of investing in girls and women
Kuala Lumpur, Malaysia, 28 May 2013 — Today, more than 4,000 global leaders and advocates from nearly 150 countries gathered in Kuala Lumpur, Malaysia, for Women Deliver 2013, the largest conference of the decade focused on the health and wellbeing of girls and women. The opening sessions of this three-day event highlighted the critical need to invest in girls and women to spur development worldwide.
Malaysian Prime Minister Honorable Dato' Sri Mohd Najib bin Tun Abdul Razak delivered welcoming remarks and discussed Malaysia’s efforts to ensure equal rights and opportunities for women as a critical component of the nation’s development and economic growth. The Prime Minister highlighted Malaysia’s success in reducing maternal mortality, and offered to share lessons learned with countries working to improve maternal health.
“We are honored to have this global village in our midst for the next few days,” said the Malaysian Prime Minister in his remarks. “We know that women play an indispensable role at every level of society. Together your strong voices will help frame the solutions, policies and strategies that will ensure progress for girls and women; of our nation, our region, and our world.”
The day’s events also included the release of new reports from the World Bank and the Guttmacher Institute quantifying the economic and social benefits of investing in girls and women. Their new research makes clear that gender inequality and gaps in reproductive and maternal health hinder global development.
The World Bank report, Investing in women’s reproductive health: Closing the deadly gap between what we know and what we do, developed for the Women Deliver 2013 conference, demonstrates that addressing the reproductive health needs of women is critical to achieving gender equality and improved development outcomes. As women constitute 40% of the world’s workforce, the report finds that investments in reproductive health are a major missed opportunity in development, and that to drive progress, proven interventions must be put into practice. These include addressing women’s agency, making improvements in the delivery of health services and increasing accountability in health systems.
The Guttmacher Institute report, Adding It Up: The Need For and Cost of Maternal and Newborn Care Estimates for 2012, provides new regional data on the unmet need for maternal and newborn care. Although there have been improvements in access to medical care during pregnancy and delivery, tens of millions of women and newborns in developing countries still do not receive the care they need. Each year, an estimated 287,000 women worldwide die from pregnancy-related causes, and approximately three million newborns do not survive past the first 28 days of life. The report finds that additional investments in reproductive and maternal health would generate immediate returns in terms of reducing disability among women and newborns, and saving lives.
“The research presented today shows that when we address the reproductive health needs of girls and women, the global economy is stronger, households are more likely to prosper and future generations have a greater chance of living long, healthy lives,” said Jeni Klugman, Director of Gender and Development at the World Bank. “Investing in reproductive health and family planning is not just the right thing to do; it’s smart economics.”
The day concluded with a discussion of progress and ongoing challenges for women in leadership roles, in fields including health, education, finance, culture, and government. Clinton Foundation Board Member Chelsea Clinton, Planned Parenthood Federation of America President Cecile Richards, Former President of Finland Tarja Halonen and Yakin Ertürk of the Council of Europe shared lessons learned and visions for female leadership in the 21st century.
The second day of the conference, 29 May, will focus on global access to family planning, and features such notable speakers as Bill & Melinda Gates Foundation Co-Chair Melinda Gates, UNFPA Executive Director Babatunde Osotimehin, Senegalese Minister of Health Awa Coll-Seck and Philippines Secretary of Health Enrique Ona, among others. The third day of the conference, 30 May, will focus on the importance of prioritizing women’s health and rights in the post-2015 development framework, and will feature UNDP Administrator Helen Clark, Special Representative for UNAIDSHRH Norwegian Crown Princess Mette-Marit and more.
###
About Women Deliver: Women Deliver is a global advocacy organization that brings together voices from around the world to call for improved health and wellbeing for girls and women. Launched in 2007, Women Deliver works globally to generate political commitment and financial investment for fulfilling Millennium Development Goal #5—to reduce maternal mortality and achieve universal access to reproductive health. Building from the groundbreaking conferences Women Deliver convened in 2007 and 2010, Women Deliver harnesses commitments, partnerships and networks to help prevent the approximately 350,000 deaths of girls and women from pregnancy- and childbirth-related causes that occur every year. Women Deliver’s message is that maternal health is both a human right and a practical necessity for sustainable development. Invest in women—it pays.
For live webcasts and archived videos of conference plenaries, presidential sessions and press conferences, please clickhere. Images are available on the Women Deliver Flickr page, and additional photography is available here.
To register for the Women Deliver conference as media—on-site or virtual—please click here.
To access the full Women Deliver 2013 schedule, please click here.
For more information on Women Deliver, please visit: www.womendeliver.org, and follow us on Facebook and Twitter. Use the hashtag #WD2013 to join the global dialogue.
'via Blog this'

Tuesday, May 21, 2013

Sharjah's new breast cancer centre sees men and women in first week - The National

"Two men and 68 women were seen by doctors during a breast cancer centre's first week of operation.

The centre at Sharjah University Hospital was launched in co-operation with the Institut Gustave Roussy, a leading cancer research facility in France, on May 12.

Dr Toufik Tabbara, an associate professor of surgery at the university and the centre's director, said most of the patients who were tested were women over 40 years old.

"We received some cases of men coming in to test and this is very important for everyone to know that not only women are at risk of getting breast cancer," he said.

"Breast cancer is deadly, but an early diagnosis can give people a chance to live."

Dr Tabbara added cases of men developing breast cancer are rare. However, the risk increases with age, with the majority of cases found among men aged 60 to 70.

The centre offers patients a rapid diagnosis of a breast lesion, the development of a treatment pathway, breast-cancer surgery, including oncoplastic (reconstructive and plastic surgery) and chemotherapy treatment.
Sheikh Mohammed bin Saqr Al Qassimi, the ministry of health undersecretary and director of Sharjah Medical Zone, said the ministry was working to increase its medical services throughout the emirate.

This includes offering pre-marital tests for couples at the Al Madam health centre to serve the Al Dhaid and Maleha areas, while mental health services will be available at Al Riffa, Al Khalidiya and Wasit health centres, in addition to existing services in Al Hamriya and Al Sabkha.

The ministry is also expanding its services for pregnant women to 12 more centres, bringing the total to 15.

'via Blog this'

Monday, May 20, 2013

HIS Breast Cancer Awareness Blog: WHY Didn't I Have a Mastectomy?

I carry the BRCA2 gene mutation, I have had several bouts with breast cancer and I have NOT had amastectomy- WHY?
When I was approaching 35 years of age, I had my first baseline mammogram since I have a maternal aunt (now 97!) who had breast cancer along with a mastectomy while in her 70’s.  When I was 36, my mother (now 88) was diagnosed withbreast cancer also in her 70’s and I was reminded it was time for my annual mammogram. One month following my mother, I too was diagnosed with breast cancer. Over a span of eleven years I had 4 positive breast cancer diagnosis, 7 surgeries including lumpectomies on one breast, the Sentinel lymph node tested and was treated with six weeks of radiation andTamoxifen for five years.

When my husband and I met with my breast surgeon after my second recurrence (18 months after my original diagnosis) we asked, “what can “we” do”? The answer at that time was, “we will keep a close watch and have a mammogram every 6 months”.  We decided that was not enough and after a great deal of research, realized there are things that we can do to help ourselves.  My husband and I sold our chain of drugstores and went into the business of a health food store. Our lifestyle changed to organic foods, a better exercise regimen, ways to reduce our stress and a full regimen of nutritional supplements.

After my last diagnosis, I decided to go for genetic testing and was diagnosed with the BRCA2 mutation. I then had a full hysterectomy (oophorectomy) due to the higher risk of developing ovarian cancer as well and the difficulty in an early diagnosis.  Sharing this information with my husband, sons and brothers, at that moment it was obvious that all of our lives would change from that point forward.

Having the BRCA2 mutation puts family members that also carry the gene at a higher risk of Prostate,PancreaticStomachMelanoma and other cancers. A few years later my brother was diagnosed with Male Breast Cancer and then Prostate cancer and after testing we know he is also a BRCA2 carrier. This means our sons (between us we have 5) now have an increased risk of also carrying the mutation and higher percentage of these cancers.

So, you ask why did I not have a mastectomy? For me, I have always felt like I do everything I can for prevention and/or an early diagnosis with a mammogram at 6 months and a breast MRI at the next 6 months. Every person’s body makes cancer cells, however having the BRCA mutation; our body is unable to destroy them. Since it appears my cancer cells go to my breast (4 times…) I feel having them helps me to find and remove the cancer. If I take away my breast, where will the cancer go? And how will I find it? Keeping my breast actually puts my mind more at ease! Having had the hysterectomy, I removed the area that is harder to diagnose. 

What I do believe is everyone is different and how we each deal with a situation is an individual decision. I appreciate what Angelina Jolie has done for her and her family. Her children (male and female) will grow up to make their own decisions about what works for them, if they too are carriers. My 3 sons have not been tested yet, however they live their life with the awareness they may be at a higher risk for a cancer diagnosis. If one or all of them are carriers, then it will be their decision as to whether they have aprophylactic mastectomy for Male Breast Cancer or take a more cautious road and keep a close watch as for all cancers. Either way, they are educated, informed and aware and that is the first step in the right direction.

My brother and I created the non-profit organization, HisBreast Cancer Awareness to help educate others about Male Breast Cancer and the BRCA genetic mutation. It’s important men know they too have breast, are aware if they have a family history of these cancers they may also be a BRCA carrier and they know what their options are if they choose to be tested. Men and women need to be educated for themselves and for their children, both daughters and sons.

Modah Ani- I Am Thankful
Editor; Vicki Singer Wolf, Co-founder
'via Blog this'

Sunday, May 19, 2013

Breast cancer: What is the risk?


Angelina Jolie
Angelina Jolie underwent a preventive double mastectomy after doctors estimated she had an 87% chance of developing breast cancer. How was that figure calculated and how does it differ from other women's risk of getting the disease?
Jolie's chances of developing breast cancer were so high because she inherited a mutated BRCA 1 gene from her mother, Marcheline Bertrand, who died of ovarian cancer at the age of 56.
The BRCA1 is present in everyone but only mutates in one in 1,000 people. Anyone with the mutation has a 50-80% chance of developing breast cancer.
But Jolie's risk figure was calculated to be even higher because of other factors, including family history.
"There are various computer programmes where you can input genetic information, family history and other things and it will calculate a figure, which is why she's got this very precise sounding number," says Dr Kat Arney, a senior science manager at Cancer Research UK.
But what are the chances of getting breast cancer if you don't have a mutated gene?
It is already "the top cancer in women both in the developed and the developing world", according to the World Health Organization - and in many countries, it's becoming more common.
Incidence increased in the UK by 90% between 1971 and 2010. It is also on the rise in the developing world.
This is partly explained by the fact that people are living longer and cancer is generally a disease that affects people in later life.
Bar chart showing incidence of breast cancer in selected countries
In the UK, the chance of developing breast cancer before the age of 30 is roughly 0.05% (one in 2,000). It goes up to 2% (one in 50) before the age of 50 and 7.7% (one in 13) before the age of 70.

Why risk increases with age

The fundamental cause of cancer is damaged or faulty genes - the instructions that tell our cells what to do. Genes are encoded within DNA, so anything that damages DNA can increase the risk of cancer. But a number of genes in the same cell need to be damaged before it becomes cancerous.
Most cancers are caused by DNA damage that accumulates over a person's lifetime. Cancers that are directly caused by specific genetic faults inherited from a parent are rare. But we all have subtle variations in our genes that may increase or reduce our risk of cancer by a small amount.
However, it is after the age of 70 that the risk is highest. A third of all incidences of breast cancer occur in women aged over 70.
Overall, a woman living in the UK has a 12% chance of getting breast cancer during her lifetime. It's the same in the US.
But increasing longevity isn't the only reason for the high incidence of breast cancer.
"There is an increase in rates in younger women and it's for a number of reasons. We know that women's lifestyles are changing and being overweight and drinking a lot of alcohol is linked to breast cancer risk," says Arney.
Changes in reproductive habits are also a factor. According to Cancer Research UK, the relative risk of developing breast cancer is estimated to increase by 3% for each year an adult woman delays becoming a mother.
The child of a Somali refugee being breastfed by its mother at a Kenyan refugee campBreastfeeding a child reduces a woman's risk of breast cancer
Women who breastfeed also reduce their risk. The longer a woman breastfeeds, the greater the protection. It's estimated that risk is reduced by 4% for every 12 months of breastfeeding.

Men and breast cancer

Breast cancer is often thought of as only affecting women. Men can also develop it, although it's much less common. It affects just one in every 100,000 men in England.
The most common symptom of breast cancer in men is a hard, painless lump that develops on one of the breasts.
This may explain why women in richer countries have a higher risk of breast cancer.
African women are four times less likely to get the disease because they have children at a younger age, have more of them and breastfeed them for longer.
On the other hand, recovery rates are higher in developed countries.
"Breast cancer survival rates [range] from 80% or over in North America, Sweden and Japan to around 60% in middle-income countries and below 40% in low-income countries," according the WHO.
But with the number of cases of breast cancer rising in the UK, and in many other countries, how many women are taking the dramatic decision that Angelina Jolie was faced with - to have a mastectomy?
The latest figures show that 18,000 operations were carried out in England in 2010/11. There are no official figures on how many of those were preventive but the figure is estimated to be between 5-10%.

Friday, May 17, 2013

Breast cancer: Taking no chances - Khaleej Times

With breast cancer claiming the lives of hundreds of thousands of women annually, many are choosing to remove their breasts before diagnosis, but is this a drastic alternative? 
Kelly Clarke talks to women who have undergone prophylactic mastectomies
As young thirty somethings in good health, most women are making decisions about career moves or family life. But a new phenomenon has been hitting the headlines recently, which has left growing numbers of women with an unenviable choice — one that could have untold effects on their personal lives.
With breast cancer the most common cancer among women worldwide, research conducted by the Breast Cancer Statistics Worldwide has listed it as the most fatal type in women.
As a result, an increasing number of women are choosing prophylactic mastectomy.
This invasive procedure, through which women have their breasts removed despite no cancer diagnosis, is considered an alternative to intensive screening.
The reason for the trend, according to Well Woman breast consultant Dr Houriya Kazim, is because of family history and the introduction of genetic testing.
“We are now able to do a simple blood test for some high-risk women to determine if she is carrying one of the genetic mutations ... if they test positive they usually choose to have prophylactic mastectomies.”
But why? In a bid to reduce the risk of developing breast cancer, many of these women see the procedure as the only way of securing a worry-free future.
Forty-year-old Briton Dr Kavita Dhingra had the prophylactic procedure at the age of 36, three years after relocating to Dubai.
A general practitioner with three young children, Dhingra decided to go for gene testing after a close friend was diagnosed with breast cancer.
“To deprive my kids of a longer life with me ... how could I live with that? I knew in my head, my gut, what I wanted ... if the test came back positive I would have the full mastectomy”.
Although her maternal grandmother was diagnosed with ovarian cancer and her mother had her ovaries removed in her early forties as a precaution, Dhingra had no family history of breast cancer and was counselled against the need for genetic testing by several doctors in the United Kingdom.
“There was no real basis for me to have the test ... my family history wasn’t strong enough.”
But she took matters into her own hands and did a private blood sample with a doctor in Dubai.
Eight weeks later, in July 2009, she was hit with the news: she had a gene mutation.
“I was given an 85 per cent chance of getting breast cancer and I thought ‘You know what, I’m not living with that, I just want the operation’.”
The gene mutations that cause breast cancer also cause ovarian cancer and the moment the results came in, Dhingra decided she would also undergo a prophylactic oophorectomy — the surgical removal of the ovaries — once she turned 40.
She will be getting back on the operating table this summer, four years after her prophylactic mastectomy.
Dhingra had given birth to her third child just six months prior to obtaining her genetic results, but said it was difficult to know if her decision regarding the prophylactic oophorectomy would have been different had she not had children at that point.
“I had three kids ... I would have loved to have had another, but I thought that was tempting fate”.
Prophylactic mastectomy
With no genetic counsellors based in Dubai, Dhingra returned to the UK in August 2009 to talk through the emotional impact of the genetic results and her upcoming surgery.
Determined to undergo the mastectomy as quickly as possible, Dhingra had the surgery in the UK a month later — where costs were significantly cheaper.
She admits the decision was rushed and described it as “a bit of a shambles”, as she had not taken the right steps leading up to surgery.
“I chose my surgeon because she was happy to do things on my terms, without me having to discuss the psychological aspect of what I was planning.”
Her refusal to go through the recommended counselling procedures is a decision she now regrets.
“I panicked a bit and I thought ‘What if I develop cancer whilst waiting for the procedure?’...that was my urgency to have it done”.
Being the only medic in the family, she felt like she had to hold everyone together, she says.
“I was in doctor mode. I wasn’t thinking like a 36-year-old feminine woman.”
Following the mastectomy, Dhingra underwent basic reconstruction with a breast surgeon. She was advised that expander implants would give the least natural result, but at the time “it was about the medical result, not the cosmetic result”.
“Do I regret that I didn’t take time out for counselling and to research the best cosmetic result? Yes. However, it’s taken me three years to recognise that.”
With her second prophylactic procedure just weeks away, Dhingra says she has no regrets about undergoing the mastectomy but cautions that prophylactic procedures are not the answer for everyone, and those considering it should talk with a doctor about their risk of developing the disease, the surgical procedure, its potential complications, and alternatives to surgery.
Dr Kazim says women categorised in the moderate- to high-risk group who go ahead with the procedure can significantly reduce their chances of developing breast cancer by up to 90 per cent. Although alternative treatments are available, “prophylactic mastectomies decrease the risk (of developing the disease) to practically nil”.
When faced with the possibility of breast cancer, and the invasive treatments that go hand in hand with the disease — radiation, chemotherapy, hormonal treatments — this is a promising statistic for many.
Carol Doeringer lost two close relatives to the illness, which prompted her decision to get a double prophylactic mastectomy in July 2011, after being told she carried a marker for an elevated risk of breast cancer.
Doeringer said it came down to facing cancer on her own terms and schedule.
For the 58-year-old consultant from the United States, no deliberation was needed.
“I made my decision to have the bilateral mastectomy literally instantly,” despite friends telling her it was a draconian answer.
With a fully supportive family behind her this was the best chance she’d have at beating the disease, she says.
“I felt that I had been given (the) early warning signals my mother, aunt and grandmother had not benefited from. I had the opportunity to get cancer before cancer got me.”
In the same operation as the mastectomy, Doeringer had simultaneous reconstruction with surgeons using abdominal fat to fill the skin left over.
Post-surgery, some doubt did plague Doeringer.
“The reconstructed breasts are not pretty to see immediately ... they have this strange look (and uncomfortable feel).”
Fortunately, Doeringer had met a woman who had undergone the same procedure and warned her of the first reveal.
“In her words ‘I want you to see the end result, because when you wake up from the surgery, you will think you got the biggest botch job on the planet’.”
But after a few months of healing, Doeringer said the reconstructed breasts “look and feel much like a natural breast”.
And in regards to feeling any different as a woman, Doeringer says: “Not in the least.”
She says while breast cancer treatments today can be very effective, they are quite debilitating and she believes more younger women are choosing prophylactic procedures while still healthy, as it aids the recovery process.
Breast cancer in the UAE
The president of Friends of Cancer Patients Ameera bin Karam says it is hard to gauge the experiences of people who have undergone prophylactic mastectomies in the country, as the whole topic of cancer is still taboo.
She stresses that the country needs to be “more proactive when it comes to breast cancer awareness” and said there was a need for regular discussions about cancer, as breast cancer is one of the UAE’s three biggest killers.
And Dr Kazim agrees, saying it is vital that women are educated on their treatment options when it comes to preventing or battling breast cancer.
“What awareness does is picks up the disease at an earlier stage.”
Support for high-risk women was lacking, which could have a detrimental effect on women choosing to undergo the procedure. Dr Kazim says support is vital.
“I don’t know of any support groups here that just focus on the high risk ... but if we end up going down the road of them having to have mastectomies, I always have them talk to another patient one-on-one who has already had the surgery.”
Whether it was a case of low procedure numbers in the country, or a patient’s unwillingness to speak up, there was a noticeable lack of women in the UAE coming forward to share their prophylactic mastectomy experience.
Karam offered some insight.
“If the cancer patient is Emirati (you will find that) culture plays a major role in making those decisions”.
Family influences can prevent many local women from sharing their experience and Karam said at FOCP there have been cases where “the patient wants to speak up, but her family does not want her to”.
She says the oncology sector in the UAE isn’t as advanced as in the West, adding that for locals superstition often takes a front seat when it comes to cancer.
The ‘big C’ is not something readily talked about — with an ‘if we say the word we might get it’ attitude, she says.
So can cultural influences and superstition really be put before a person’s health?

'via Blog this'